Ameritas Investment Partners, Inc. Applied Therapeutics Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q3 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 9,419 shares of APLT stock, worth $6,687. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,419
Previous 9,419
-0.0%
Holding current value
$6,687
Previous $43,000
86.05%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding APLT
# of Institutions
140Shares Held
112MCall Options Held
1.68MPut Options Held
1.91M-
Janus Henderson Group PLC London, X010.5MShares$7.48 Million0.05% of portfolio
-
Morgan Stanley New York, NY9.9MShares$7.03 Million0.01% of portfolio
-
Vr Adviser, LLC New York, NY9.83MShares$6.98 Million8.65% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$5.68 Million1.78% of portfolio
-
Franklin Resources Inc San Mateo, CA6.8MShares$4.83 Million0.02% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $34.1M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...